Paul Tudor Jones’s Legend Biotech LEGN Stock Holding History

Paul Tudor Jones’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$839K	Sell	29,066 -26,036	-47%	-$702K	﹤0.01%	2537
2026 Q1	$997K	Buy	55,102 +1,802	+3%	+$34.4K	﹤0.01%	2376
2025 Q4	$1.16M	Buy	53,300 +628	+1%	+$18K	﹤0.01%	2165
2025 Q3	$1.72M	Buy	52,672 +3,167	+6%	+$117K	﹤0.01%	1902
2025 Q2	$1.76M	Sell	49,505 -22,555	-31%	-$731K	﹤0.01%	1745
2025 Q1	$2.44M	Buy	+72,060	New	+$2.58M	0.01%	1200
2024 Q4	–	Sell	-5,572	Closed	-$231K	–	3292
2024 Q3	$272K	Buy	+5,572	New	+$297K	﹤0.01%	2373
2020 Q3	–	Sell	-8,771	Closed	-$373K	–	1435
2020 Q2	$373K	Buy	+8,771	New	+$343K	0.02%	811

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Paul Tudor Jones's LEGN Position: Q2 2026 in Review

Paul Tudor Jones reduced its Legend Biotech (LEGN) stake by 47% in Q2 2026, selling an estimated $702K and leaving 29,066 shares worth $839K. The position accounts for ﹤0.01% of the portfolio, ranked #2537.

Paul Tudor Jones first reported a position in LEGN in Q2 2020 and has held it in 8 quarters since. The position peaked at $2.44M in Q1 2025. 217 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Paul Tudor Jones held 29,066 shares of Legend Biotech worth $839K as of Q2 2026.
Paul Tudor Jones sold 26,036 Legend Biotech shares in Q2 2026, an estimated $702K.
Legend Biotech made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2537 holding.
Paul Tudor Jones first reported a position in Legend Biotech in Q2 2020 and has held it in 8 quarters since.
Paul Tudor Jones's Legend Biotech position peaked at $2.44M in Q1 2025.
217 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.